Faculty

Institution

Unit

Venue

Bouthaina S. Dabaja, MD, FASTRO

The University of Texas MD Anderson Cancer Center

Affiliations

Department Of Breast Radiation Oncology

Department Of Experimental Radiation Oncology

Department Of Lymphoma And Myeloma

Division Of Radiation Oncology

The University of Texas MD Anderson Cancer Center

Bouthaina S. Dabaja, MD, FASTRO, is a Professor of Radiation Oncology at The University of Texas MD Anderson Cancer Center. Her research focuses on radiation therapy for hematological malignancies, particularly lymphoid neoplasia, cutaneous lymphomas, and leukemia. Recent work includes leading ILROG multicenter studies on bridging radiotherapy before CAR-T cell therapy for B-cell lymphomas, and investigating how SARS-CoV-2 mRNA vaccines sensitize tumors to immune checkpoint blockade. She has published in Nature, Blood, and the International Journal of Radiation Oncology*Biology*Physics, and co-authored ASTCT clinical recommendations for stem cell transplant in mycosis fungoides. A Fellow of ASTRO, she is recognized internationally for advancing lymphoma-directed radiation strategies.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Bouthaina S. Dabaja, MD, FASTRO

The University of Texas MD Anderson Cancer Center

You can click a keyword to filter the displayed items

oncology radiation oncology lymphoid neoplasia medicine hematology radiation therapy hematological malignancies immunology radiation leukemia pathology cancer research cancer care lymphatic disease clinical radiation oncology cancer treatment immunotherapy cellular therapy cell therapy surgical oncology cell transplantation nuclear medicine bone marrow transplantation anatomical pathology stem cell transplantation cancer immunotherapy cancer imaging surgical pathology clinical transplantation thoracic oncology radiation biology medical imaging hodgkin lymphoma jama oncology positron emission tomography histopathology adult t-cell leukemia-lymphoma cancer management radiation effects pharmacotherapy oncologic imaging medicinal research cancer biology mycosis fungoides multiple myeloma brain tumor research proton therapy clinical mycology gastrointestinal oncology transplantation medicine inotuzumab ozogamicin hematologic malignancies malignant blood disorders high-dose chemotherapy large b-cell lymphoma combined modality therapy clinical guidance computed tomography radiation therapy planning clinical dermatology radiation exposure breast oncology combined modality treatment mediastinal lymphoma sezary syndrome covid-19 pandemic immunohaematology metronomic chemotherapy dose guidelines modern radiation therapy consolidative radiation therapy advanced-stage hodgkin lymphoma cohort studies radiomics double hit lymphoma effective modality

Notable Scholarly Works

Notable Federal Grants

Collaborators

Executive Summary of the American Radium Society Appropriate Use Criteria for Extranodal Nk/T-Cell Lymphoma. International Journal of Radiation Oncology*Biology*Physics (2026)

pathologymedicinelymphoid neoplasiaoncologyhematological malignanciesleukemiaadult t-cell leukemia-lymphomaexecutive summaryhematologyjama oncologyextranodal nk/t-cell lymphoma

Radiotherapy for Indolent Primary Cutaneous B-Cell Lymphoma: An International Multicenter Ilrog Analysis. Blood (2026)

lymphoid neoplasiaoncologyhematological malignanciesradiation oncologyleukemiadermatologyhematology

2180 Mr- Linac Successfully Guided the Treatment of a Free-Moving Mesenteric Mass. Radiotherapy and Oncology (2025)

mr- linac successfullyparticle acceleratorsinstrumentationfree-moving mesenteric massaccelerator technologyparticle beamaccelerator physicsradiation oncologyradiationradiology

Acalabrutinib Plus Rituximab Followed by Brexucabtagene Autoleucel for Frontline Treatment of High-Risk Mantle Cell Lymphoma: The Window-3 Clinical Trial. Blood (2025)

clinical trialsmedicinelymphoid neoplasiaoncologyfrontline treatmenthematological malignanciesradiation oncologyleukemiapharmacotherapybrexucabtagene autoleucelhematologywindow-3 clinical trialsystemic treatment

An International Lymphoma Radiation Oncology Group Study of Radiation Therapy for Bilateral Indolent Orbital Adnexal Lymphomas. International Journal of Radiation Oncology*Biology*Physics (2025)

lymphoid neoplasiaoncologycancer letterradiation oncologyradiationradiation therapy

A Robust Radiotherapy Continuity System That Enables Patient Treatments During a Cybersecurity Event. International Journal of Radiation Oncology*Biology*Physics (2025)

cybersecurity eventradiation oncologysystems engineeringradiationenables patient treatmentsadaptive radiotherapycyberneticscybersecurity systemscyber-physical systemsmedical physics

Association of Car T Cell Kinetics With Outcomes After Standard of Care Brexucabtagene Autoleucel for Relapsed/Refractory Mantle Cell Lymphoma. Blood (2025)

cancer immunotherapylymphoid neoplasiaoncologyhematological malignanciescell transplantationradiation oncologyleukemiacare brexucabtagene autoleucelcellular therapytranslational medicineimmunotherapyimmunologycell therapyhematology

Astct and Usclc Clinical Practice Recommendations for Allogeneic Stem Cell Transplant in Mycosis Fungoides and SéZary Syndrome. Journal of the American Academy of Dermatology (2025)

Amrita GoyalDaniel O'LearyBouthaina DabajaWen-Kai WengJasmine ZainCorey CutlerJoan GuitartYoun H KimLarisa J GeskinRichard T HoppeLynn D WilsonAnne W BeavenSteve HorwitzPamela B AllenStefan K BartaKimberly BohjanenJonathan E BrammerJoi B CarterNneka ComfereJennifer A DeSimoneKathryn DusenberyMadeleine DuvicAuris HuenDeepa JagadeeshChris R KelseyMichael S KhodadoustMary Jo LechowiczNeha Mehta-ShahAlison J MoskowitzElise A OlsenChristina PohBarbara ProChristiane QuerfeldCraig SauterLubomir SokolOlayemi SokumbiRyan A WilcoxJohn A ZicAlejandro GruMehdi HamadaniFrancine Foss

clinical transplantationmedicinesezary syndromestem cell transplantationtransplantation medicinecell transplantationmycosis fungoidescellular therapystem cells

Brexucabtagene Autoleucel (Brexu-Cel) as Consolidation Treatment in Adults With B-Cell Acute Lymphoblastic Leukemia.. Journal of Clinical Oncology (2025)

pathologybrexucabtagene autoleucelmedicinelymphoid neoplasiaoncologyhematological malignanciesleukemiatranslational medicineimmunotherapyadult t-cell leukemia-lymphomabone marrow transplantationconsolidation treatmenthematology

Bridging Radiotherapy Before Chimeric Antigen Receptor T Cells for B-Cell Lymphomas: An Ilrog Multicenter Study. Blood Advances (2025)

Nikhil Yegya-RamanJohn P. PlastarasChristopher M WrightMonica R. CheliusSiqi ZhangJonathan A BaronHarper HubbelingAustin J SimTimothy J RobinsonMichael D JainBrandon S. ImberBeatrice FregoneseJoachim YahalomColton LadburySavita DandapaniChelsea C PinnixJillian R. GuntherPenny Q. FangSusan Y WuBouthaina S DabajaJoanna C YangJessica ChewSteve BraunsteinSumi SinhaNathan DenlingerSusan SunStephanie A TerezakisGukan SakthivelLouis S. ConstineAmit K ChowdhryPatrick M. ReaganSkyler BurkeYolanda D TsengMichael J. LaRiviereAmit MaityStephen J. SchusterElise A ChongNicholas B Figura

ilrog multicenter studyradiation therapyb-cell lymphomasimmunotherapyimmunologyantigen receptor t-cells

1
2
3
4
5
37
10 / page

Bouthaina S. Dabaja, MD, FASTRO

The University of Texas MD Anderson Cancer Center

Affiliations

Department Of Breast Radiation Oncology

Department Of Experimental Radiation Oncology

Department Of Lymphoma And Myeloma

Division Of Radiation Oncology

The University of Texas MD Anderson Cancer Center

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Bouthaina S. Dabaja, MD, FASTRO

The University of Texas MD Anderson Cancer Center

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

Executive Summary of the American Radium Society Appropriate Use Criteria for Extranodal Nk/T-Cell Lymphoma. International Journal of Radiation Oncology*Biology*Physics (2026)

pathologymedicinelymphoid neoplasiaoncologyhematological malignanciesleukemiaadult t-cell leukemia-lymphomaexecutive summaryhematologyjama oncologyextranodal nk/t-cell lymphoma

Radiotherapy for Indolent Primary Cutaneous B-Cell Lymphoma: An International Multicenter Ilrog Analysis. Blood (2026)

lymphoid neoplasiaoncologyhematological malignanciesradiation oncologyleukemiadermatologyhematology

2180 Mr- Linac Successfully Guided the Treatment of a Free-Moving Mesenteric Mass. Radiotherapy and Oncology (2025)

mr- linac successfullyparticle acceleratorsinstrumentationfree-moving mesenteric massaccelerator technologyparticle beamaccelerator physicsradiation oncologyradiationradiology

Acalabrutinib Plus Rituximab Followed by Brexucabtagene Autoleucel for Frontline Treatment of High-Risk Mantle Cell Lymphoma: The Window-3 Clinical Trial. Blood (2025)

An International Lymphoma Radiation Oncology Group Study of Radiation Therapy for Bilateral Indolent Orbital Adnexal Lymphomas. International Journal of Radiation Oncology*Biology*Physics (2025)

lymphoid neoplasiaoncologycancer letterradiation oncologyradiationradiation therapy

A Robust Radiotherapy Continuity System That Enables Patient Treatments During a Cybersecurity Event. International Journal of Radiation Oncology*Biology*Physics (2025)

cybersecurity eventradiation oncologysystems engineeringradiationenables patient treatmentsadaptive radiotherapycyberneticscybersecurity systemscyber-physical systemsmedical physics

Association of Car T Cell Kinetics With Outcomes After Standard of Care Brexucabtagene Autoleucel for Relapsed/Refractory Mantle Cell Lymphoma. Blood (2025)

Astct and Usclc Clinical Practice Recommendations for Allogeneic Stem Cell Transplant in Mycosis Fungoides and SéZary Syndrome. Journal of the American Academy of Dermatology (2025)

clinical transplantationmedicinesezary syndromestem cell transplantationtransplantation medicinecell transplantationmycosis fungoidescellular therapystem cells

Brexucabtagene Autoleucel (Brexu-Cel) as Consolidation Treatment in Adults With B-Cell Acute Lymphoblastic Leukemia.. Journal of Clinical Oncology (2025)

Bridging Radiotherapy Before Chimeric Antigen Receptor T Cells for B-Cell Lymphomas: An Ilrog Multicenter Study. Blood Advances (2025)

ilrog multicenter studyradiation therapyb-cell lymphomasimmunotherapyimmunologyantigen receptor t-cells

1
2
3
4
5
37
10 / page